Acid Reducer

Manufacturer
Major Pharmaceuticals | Ranbaxy Pharmaceuticals Inc. | Shasun Pharmaceuticals Limited
Effective date
2019-02-20
Label type
HUMAN OTC DRUG LABEL
Version
4
Source
legacy-cache
Hydrated at
2026-08-02 00:30:42

Label at a glance#

ProductAcid Reducer
Active ingredientRANITIDINE HYDROCHLORIDE
Label structure9 sections

Indications and uses

relieves heartburn associated with acid indigestion and sour stomach prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain foods and beverages

Dosage and administration

adults and children 12 years and over: to relieve symptoms, swallow 1 tablet with a glass of water to prevent symptoms, swallow 1 tablet with a glass of water 30 to 60 minutes before eating food or drinking beverages that cause heartburn can be used up to twice daily (do not take more than 2 tablets in 24 hours) children under 12 years: ask a doctor

Storage and handling

TAMPER EVIDENT: DO NOT USE IF THE CARTON OR PRINTED FOIL UNDER CAP IS OPEN OR TORN. store at 20° - 25° C (68° - 77° F) avoid excessive heat or humidity this product is sodium and sugar free

Label contents#

Full prescribing information#

ACTIVE INGREDIENT (IN EACH TABLET)

OTC - ACTIVE INGREDIENT SECTION

Ranitidine 150 mg (as ranitidine hydrochloride, USP 168 mg)

PURPOSE

OTC - PURPOSE SECTION

Acid reducer

USES

INDICATIONS & USAGE SECTION

  • relieves heartburn associated with acid indigestion and sour stomach
  • prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain foods and beverages

WARNINGS

WARNINGS SECTION

Allergy alert: Do not use if you are allergic to ranitidine or other acid reducers

Do Not Use

OTC - DO NOT USE SECTION

  • if you have trouble or pain swallowing food, vomiting with blood, or bloody or black stools. These may be signs of a serious condition. See your doctor.
  • with other acid reducers
  • if you have kidney disease, except under the advice and supervision of a doctor

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

  • frequent chest pain
  • frequent wheezing, particularly with heartburn
  • unexplained weight loss
  • nausea or vomiting
  • stomach pain
  • had heartburn over 3 months. This may be a sign of a more serious condition.
  • heartburn with lightheadedness, sweating or dizziness
  • chest pain or shoulder pain with shortness of breath; sweating; pain spreading to arms, neck or shoulders; or lightheadedness

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • your heartburn continues or worsens
  • you need to take this product for more than 14 days

If pregnant or breast-feeding

OTC - PREGNANCY OR BREAST FEEDING SECTION

Ask a health professional before use.

Keep Out of Reach of Children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

DIRECTIONS

DOSAGE & ADMINISTRATION SECTION

  • adults and children 12 years and over:
    • to relieve symptoms, swallow 1 tablet with a glass of water
    • to prevent symptoms, swallow 1 tablet with a glass of water 30 to 60 minutes before eating food or drinking beverages that cause heartburn
    • can be used up to twice daily (do not take more than 2 tablets in 24 hours)
  • children under 12 years: ask a doctor

OTHER INFORMATION

STORAGE AND HANDLING SECTION

  • TAMPER EVIDENT: DO NOT USE IF THE CARTON OR PRINTED FOIL UNDER CAP IS OPEN OR TORN.
  • store at 20° - 25° C (68° - 77° F)
  • avoid excessive heat or humidity
  • this product is sodium and sugar free

INACTIVE INGREDIENTS

INACTIVE INGREDIENT SECTION

Colloidal silicon dioxide, croscarmellose sodium, hypromellose, iron oxide red, magnesium stearate, microcrystalline cellulose, polyethylene glycol, talc, titanium dioxide

QUESTIONS?

OTC - QUESTIONS SECTION

call 1-800-406-7984

PRINCIPAL DISPLAY PANEL - 150 mg Tablet Blister Pack Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

MAJOR®
NDC 0904-6350-24

MAXIMUM STRENGTH

RANITIDINE 150
Ranitidine Tablets USP, 150 mg
Acid Reducer

Prevents and Relieves
Hearburn
Associated with Acid Indigestion and Sour Stomach

COMPARE TO the active ingredient of
ZANTAC 150®*

ACTUAL SIZE

24 Tablets

Principal Display Panel - 150 mg Tablet Blister Pack Carton
Principal Display Panel - 150 mg Tablet Blister Pack Carton

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
0904-6350-242021-02-16C16284748780-1ba0f9c33-3975-a910-e053-dadaa90a0b85Drug Facts
0904-6350-512021-02-16C16284748780-1ba0f9c33-3975-a910-e053-dadaa90a0b85Drug Facts
0904-6350-242021-01-29C16284748780-1ba0f9c33-3975-a910-e053-dadaa90a0b85Drug Facts
0904-6350-512021-01-29C16284748780-1ba0f9c33-3975-a910-e053-dadaa90a0b85Drug Facts

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0904-6350-24EA - Each0904-6350db7074cd-cc88-4181-a2e9-990427ac243a12013-12-02
0904-6350-51EA - Each0904-635025ea3f5e-3225-4d4b-ad5a-3ba61810a01812013-12-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
RANITIDINE HYDROCHLORIDEACTIVE INGREDIENTBK76465IHM2
RANITIDINEACTIVE MOIETY884KT10YB72
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61U2
CROSCARMELLOSE SODIUMINACTIVE INGREDIENTM28OL1HH482
FERRIC OXIDE REDINACTIVE INGREDIENT1K09F3G6752
HYPROMELLOSESINACTIVE INGREDIENT3NXW29V3WO2
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I302
POLYETHYLENE GLYCOLSINACTIVE INGREDIENT3WJQ0SDW1A2
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU42
TALCINACTIVE INGREDIENT7SEV7J4R1U2
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JP2

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 12 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
0904-63500904-6350-24, 0904-6350-51

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 10 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 5 · 261 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
TALCTALC7SEV7J4R1UTABLET, CHEWABLE / ORAL202 mgExact identifier — unii candidate
35 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30LOZENGE / ORAL420 mgExact identifier — unii candidate
39 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30SUSPENSION / ORAL64 mgExact identifier — unii candidate
39 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4FILM, SOLUBLE / ORAL2 mgExact identifier — unii candidate
49 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30POWDER / RESPIRATORY (INHALATION)0.13 mgExact identifier — unii candidate
39 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPSUSPENSION / ORAL113 mgExact identifier — unii candidate
40 equally ranked IID candidates
TALCTALC7SEV7J4R1UTABLET, CHEWABLE, EXTENDED RELEASE / ORAL18 mgExact identifier — unii candidate
35 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30POWDER / TOPICAL104 mgExact identifier — unii candidate
39 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPTABLET, DELAYED RELEASE / ORAL66 mgExact identifier — unii candidate
40 equally ranked IID candidates
TALCTALC7SEV7J4R1UCAPSULE, COATED / ORAL87 mgExact identifier — unii candidate
35 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UGRANULE, DELAYED RELEASE / ORAL789.6 mgExact identifier — unii candidate
28 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPCAPSULE, COATED PELLETS / ORAL4.4 mgExact identifier — unii candidate
40 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPSUPPOSITORY, EXTENDED RELEASE / INTRAUTERINE1 mgExact identifier — unii candidate
40 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4TAMPON / VAGINALNAExact identifier — unii candidate
49 equally ranked IID candidates
HYPROMELLOSESHYPROMELLOSE3NXW29V3WOTABLET, FILM COATED / ORAL582 mgExact identifier — unii candidate
27 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4CAPSULE, EXTENDED RELEASE / ORAL168 mgExact identifier — unii candidate
49 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30CAPSULE / ORAL256.4 mgExact identifier — unii candidate
39 equally ranked IID candidates
CROSCARMELLOSE SODIUMCROSCARMELLOSE SODIUMM28OL1HH48TABLET, COATED / ORAL224 mgExact identifier — unii candidate
22 equally ranked IID candidates
HYPROMELLOSESHYPROMELLOSE3NXW29V3WOTABLET, ORALLY DISINTEGRATING / ORAL41 mgExact identifier — unii candidate
27 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET, FOR SUSPENSION / ORAL131 mgExact identifier — unii candidate
39 equally ranked IID candidates
CROSCARMELLOSE SODIUMCROSCARMELLOSE SODIUMM28OL1HH48CAPSULE, COATED PELLETS / ORAL198 mgExact identifier — unii candidate
22 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4SOLUTION / ORAL336 mgExact identifier — unii candidate
49 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30RING / VAGINAL2 mgExact identifier — unii candidate
39 equally ranked IID candidates
TALCTALC7SEV7J4R1UGRANULE, DELAYED RELEASE / ORAL525 mgExact identifier — unii candidate
35 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4TABLET / ORAL750 mgExact identifier — unii candidate
49 equally ranked IID candidates
TALCTALC7SEV7J4R1UTABLET, DELAYED RELEASE / ORAL349 mgExact identifier — unii candidate
35 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30LOZENGE / TRANSMUCOSAL100 mgExact identifier — unii candidate
39 equally ranked IID candidates
TALCTALC7SEV7J4R1UTABLET / RECTAL32.4 mgExact identifier — unii candidate
35 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UTABLET, EXTENDED RELEASE / ORAL5119 mgExact identifier — unii candidate
28 equally ranked IID candidates
HYPROMELLOSESHYPROMELLOSE3NXW29V3WOGEL / RECTAL348 mgExact identifier — unii candidate
27 equally ranked IID candidates
TALCTALC7SEV7J4R1UCAPSULE / ORAL729 mgExact identifier — unii candidate
35 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPPOWDER, FOR SUSPENSION / ORAL297 mgExact identifier — unii candidate
40 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30CAPSULE, DELAYED RELEASE / ORAL1060 mgExact identifier — unii candidate
39 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4SUPPOSITORY / RECTAL14 mgExact identifier — unii candidate
49 equally ranked IID candidates
TALCTALC7SEV7J4R1UTABLET, EXTENDED RELEASE / ORAL300 mgExact identifier — unii candidate
35 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4PELLET / ORAL34 mgExact identifier — unii candidate
49 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPCAPSULE / ORAL72 mgExact identifier — unii candidate
40 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UCAPSULE / ORAL2169 mgExact identifier — unii candidate
28 equally ranked IID candidates
FERRIC OXIDE REDFERRIC OXIDE RED1K09F3G675TABLET / ORAL8 mgExact identifier — unii candidate
21 equally ranked IID candidates
CROSCARMELLOSE SODIUMCROSCARMELLOSE SODIUMM28OL1HH48TABLET, FILM COATED / ORAL330 mgExact identifier — unii candidate
22 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4FILM, EXTENDED RELEASE / TRANSDERMAL49 mgExact identifier — unii candidate
49 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET, CHEWABLE / ORAL127 mgExact identifier — unii candidate
39 equally ranked IID candidates
HYPROMELLOSESHYPROMELLOSE3NXW29V3WOGRANULE, FOR SUSPENSION / ORAL1.7 mgExact identifier — unii candidate
27 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4TABLET, CHEWABLE / ORAL254 mgExact identifier — unii candidate
49 equally ranked IID candidates
CROSCARMELLOSE SODIUMCROSCARMELLOSE SODIUMM28OL1HH48TABLET, FOR SUSPENSION / ORAL1875 mgExact identifier — unii candidate
22 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30WAFER / ORAL66 mgExact identifier — unii candidate
39 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4GEL / VAGINAL8 %w/wExact identifier — unii candidate
49 equally ranked IID candidates
FERRIC OXIDE REDFERRIC OXIDE RED1K09F3G675TABLET / SUBLINGUAL1 mgExact identifier — unii candidate
21 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPTABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL42 mgExact identifier — unii candidate
40 equally ranked IID candidates
FERRIC OXIDE REDFERRIC OXIDE RED1K09F3G675CAPSULE, COATED / ORAL0.12 mgExact identifier — unii candidate
21 equally ranked IID candidates
HYPROMELLOSESHYPROMELLOSE3NXW29V3WOSOLUTION / OPHTHALMIC0.5 %w/vExact identifier — unii candidate
27 equally ranked IID candidates
HYPROMELLOSESHYPROMELLOSE3NXW29V3WOSYRUP / ORAL250 mgExact identifier — unii candidate
27 equally ranked IID candidates
TALCTALC7SEV7J4R1UTABLET, COATED / ORAL320.75 mgExact identifier — unii candidate
35 equally ranked IID candidates
TALCTALC7SEV7J4R1UPOWDER / TOPICAL9235 mgExact identifier — unii candidate
35 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPCAPSULE / RESPIRATORY (INHALATION)NAExact identifier — unii candidate
40 equally ranked IID candidates
FERRIC OXIDE REDFERRIC OXIDE RED1K09F3G675CAPSULE / ORAL5 mgExact identifier — unii candidate
21 equally ranked IID candidates
FERRIC OXIDE REDFERRIC OXIDE RED1K09F3G675TABLET, EXTENDED RELEASE / ORAL7 mgExact identifier — unii candidate
21 equally ranked IID candidates
CROSCARMELLOSE SODIUMCROSCARMELLOSE SODIUMM28OL1HH48TABLET, EXTENDED RELEASE / ORAL392 mgExact identifier — unii candidate
22 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4CAPSULE, COATED / ORAL3 mgExact identifier — unii candidate
49 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET, ORALLY DISINTEGRATING / ORAL187 mgExact identifier — unii candidate
39 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A200536-001RANITIDINE HYDROCHLORIDERANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-28

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-2884e616aacf4f…
2026-08-18 06:07:402026-07A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-28caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-28011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-2831067a03dcf5…
2025-08-23 18:47 UTC2025-08A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-286a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-28fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-28b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-2803ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-282680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-285bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-28d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-28d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-2879d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-28301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-281e350fbaab3a…
2024-05-31 18:47 UTC2024-05A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-288072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-285c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-285d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-284b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-2874a2ff9319b5…
2022-03-09 01:35 UTC2022-03A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-28bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-28782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-2887673890dc5c…
2021-03-12 10:30 UTC2021-03A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-285aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-288869cabd3fbd…
2020-11-12 02:37 UTC2020-11A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-28c0c555d07b60…
2019-12-14 00:12 UTC2019-12A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-283f01610625f2…
2019-09-15 20:21 UTC2019-09A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-28b00525d2431f…
2019-07-19 19:46 UTC2019-07A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-28ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-286a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-281c564ffb4f44…
2023-12-20 04:57 UTC2023-12A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-28ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-28a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-289b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-28a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-283f0d92c62455…
2023-05-13 08:27 UTC2023-05A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-28053a50430f4f…
2023-01-26 05:58 UTC2023-01A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-283bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-283a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A200536-001RANITIDINE HYDROCHLORIDEEQ 150MG BASETABLET / ORAL2011-06-28f41ea6bd6efb…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
8b8dd1f1-d9e7-4fe5-aecf-07bb989f66822cbbdd6a-d429-4e1c-8c1a-4ceb29bc26052021-02-16WarningsExact identifier
spl set id: 2cbbdd6a-d429-4e1c-8c1a-4ceb29bc2605

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.